ActivatorPep™ SARS-CoV-2 Prot_N B.1.1.7, WT (CA-LX128)

Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Specific Inquiry

Add to Cart

Product Name
ActivatorPep™ SARS-CoV-2 Prot_N B.1.1.7, WT

Cat. No.
CA-LX128

Product Summary
Creative Biolabs provides an extensive cell activation reagents including Expansion Kits and Activator peptides for global custom, which are suitable to many applications, such as in vitro stimulation antigen-specific cells. s are pools of lyophilized peptides, consisting mainly of 15-mer sequences with 11 amino acids overlap. SARS-CoV-2 Prot_N B.1.1.7 WT Reference Pool consists of the 9 homologous peptides of the Wuhan sequence and serves as a control. Which can be used for in vitro stimulation of SARS-CoV-2-specific CD4+ and CD8+ T cells .

Background Information
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was first detected in December 2019 in Wuhan, China. Since that time the virus kept mutating, leading to new virus variants. The B.1.1.7 lineage, also known as VUI202012/01 or VOC202012/01, is a SARS-CoV-2 variant that was first discovered in Kent, UK in September 2020. The mutations of this variant affect also immune relevant parts of structural SARS-CoV-2 proteins and the respective sequences are available in GISAID, a genome data base, e.g. reference sequence EPI_ISL_756151. The B.1.1.7 lineage has been found to be more infectious than former variants and has become quickly the dominant strain in the UK. In total there are 4 mutations in the nucleocapsid phosphoprotein ("N") of the B.1.1.7 lineage compared to the Wuhan variant (reference genome GenBank MN908947.3): D3L, R203K, G204R, S235F.

Applications
Stimulation Reagents

Cross-reactivity
No significant cross-reactivity was observed among analytes in this panel.

Species Reactivity
Human

Purity or Quality Grade
Research Grade

Downstream Application
Pulsing of antigen-presenting cells for research;
Detection and analysis of antigen-specific CD4+ and CD8+ effector/memory T cells in PBMCs;

Product Size
for stimulation of 1×108 cells

Shipping Condition
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Storage Conditions
Store at -20°C.

Shelf life
> 6 Months from date of receipt under proper storage condition.

Product Use Statement
For research use only, not for diagnostic or therapeutic use.

Product Features
Efficient expansion and increased survival rate of Ag-specific T cells;
Provides a gentle activation stimulus that maintains high viability of activated and expanded T cells;

Principle of the Assay
In vitro stimulation of antigen-specific T cells with Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.

Research Category
Immunology

Panel Type
Stimulation for CD4+ and CD8+ T cells

Customer Reviews and Q&As

There are currently no customer reviews or questions for ActivatorPep™ SARS-CoV-2 Prot_N B.1.1.7, WT (CA-LX128). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

ActivatorPep™ SARS-CoV-2 Prot_N B.1.1.7, WT (CA-LX128)

Specific Inquiry

Customer Reviews and Q&As

Related Products

CAR-T Cytokine Release Test Kits

T Cell Culture & Isolation Kits

Autoimmune Diseases

CAR Construction Kits

CAR Expression Test Kits

CAR Transfection Kits